Regarding the rumor that Yin Min, the Chief Commercial Officer of BeiGene (BGNE. NS, 06160. HK, 688235. SH) in Greater China, has been investigated by regulatory authorities, the company responded positively at around 4 pm on October 25th.
BeiGene released a statement stating that it has recently learned that an employee of the company is cooperating with the relevant investigation. According to the current understanding, the incident involving the employee is not related to BeiGene.
The company will continue to value and adhere to the operating principles of legality, compliance, and high ethical standards, "BeiGene said.
BeiGene is a pharmaceutical company jointly listed on NASDAQ, Hong Kong Stock Exchange, and A-share Science and Technology Innovation Board. As of the afternoon closing on October 25th, BeiGene's market value was 238.5 billion yuan.